Patents by Inventor David Saul Cohen

David Saul Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080131475
    Abstract: The present invention relates to uses of dual PPAR agonist compounds and delivery devices containing such compounds. The compounds are useful as pharmaceuticals for the treatment and/or prevention of VSMC proliferation, e.g., stenosis and restenosis, especially restenosis in diabetic patients.
    Type: Application
    Filed: January 17, 2006
    Publication date: June 5, 2008
    Inventor: David Saul Cohen
  • Patent number: 7019010
    Abstract: The present invention relates to a pharmaceutical composition, comprising (a) a phosphodiesterase 5 inhibitor or a pharmaceutically acceptable salt thereof and (b) at least one of the active ingredients selected from the group consisting of (i) an anti-diabetic agent; (ii) HMG-Co-A reductase inhibitors; (iii) an anti-hypertensive agent; and (iv) a serotonin reuptake inhibitor (SSRI) or, in each case, or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: September 6, 2002
    Date of Patent: March 28, 2006
    Assignee: Novertis AG
    Inventor: David Saul Cohen
  • Publication number: 20030139429
    Abstract: The present invention relates to a pharmaceutical composition, comprising
    Type: Application
    Filed: September 6, 2002
    Publication date: July 24, 2003
    Inventor: David Saul Cohen
  • Publication number: 20030114469
    Abstract: The present invention relates to a pharmaceutical composition, comprising
    Type: Application
    Filed: August 28, 2002
    Publication date: June 19, 2003
    Inventor: David Saul Cohen